Mar 25, 2014

Finding effective cancer therapies through loss of function genetic screens

Current Opinion in Genetics & Development
Rene Bernards

Abstract

Intrinsic or acquired drug resistance often limits the success of cancer treatment. Loss of function genetic screens can help identify mechanisms of drug resistance and thereby deliver strategies to combat resistance. A further application of these genetic screens is the identification of drug targets whose inactivation is only effective in a specific context. This synthetic lethality approach enables the identification of drugs that act only in cancer cells having a cancer-specific mutation and the discovery of potent combination therapies. This review focuses on the question how functional genetic screens can help to improve the treatment of cancer.

  • References29
  • Citations9

Citations

Mentioned in this Paper

Chemical Burns
ErbB-2 Receptor
Biochemical Pathway
MED12 gene
Antineoplastic Agents
Tumor Suppressor Genes
Transfection
Central Neuroblastoma
BRAF protein, human
Antibiotic Resistance, Neoplasm

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Katrien Berns, Rene Bernards
Cold Spring Harbor Perspectives in Biology
Alan Ashworth, Rene Bernards
Nature Reviews. Drug Discovery
Alexandra Flemming
Nature Reviews. Cancer
Nicola McCarthy
© 2020 Meta ULC. All rights reserved